Arrowhead Pharmaceuticals...

NASDAQ: ARWR · Real-Time Price · USD
20.50
1.72 (9.16%)
At close: Aug 15, 2025, 3:59 PM
20.90
1.93%
After-hours: Aug 15, 2025, 07:44 PM EDT

Arrowhead Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-178.65M 367.86M -175.22M -173.34M -173.98M -127M -132.86M -111.02M -104.13M 47.68M -41.81M -85.94M -72.05M 44.37M -62.87M -63.37M -29.92M -26.82M -20.73M
Depreciation & Amortization
1.68M 6.08M 5.24M 5.03M 4.78M 4.53M 4.26M 3.86M 3.28M 2.67M 2.69M 2.66M 2.59M 2.59M 2.57M 2.5M 2M 1.92M 1.85M
Stock-Based Compensation
13.04M 16.03M 15.21M 19.47M 17.05M 17.75M 19.69M 18.18M 19.95M 20.61M 19.39M 29.2M 33.39M 33.8M 24.5M 34.62M 18.55M 15.36M 8.14M
Other Working Capital
-33.86M 50.18M -8.01M 16.27M 13.46M -693K 1.59M 30.2M -12.85M -85.81M -19.09M -9.96M -32.44M -28.16M -26.52M 13.79M -35.93M 260.02M -13.4M
Other Non-Cash Items
27.17M 24.55M 15.94M 3.68M 12.08M 8.98M 1.94M 6.29M 4.21M 4.29M 3.54M -426K 3.29M 4.76M -280K 124K -51K 495K -302K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a -2.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-17.96M 45.52M -7.44M 7.95M 24.64M 3.37M -10.87M 59.44M 55.25M -106.91M -59.32M -14.15M -36.07M -22.8M -25.27M 2.01M -20.18M 272.92M -27.88M
Operating Cash Flow
-154.72M 460.05M -146.27M -137.22M -115.42M -92.38M -117.84M -25.26M -21.45M -31.67M -75.52M -68.67M -68.85M 62.73M -61.35M -24.12M -29.61M 263.87M -38.92M
Capital Expenditures
-2.36M -5.3M -7.52M -24.29M -14.45M -34.08M -68.66M -63.91M -46.6M -27.31M -38.91M -32.71M -9.54M -4.75M -5.78M -8.2M -3.93M -7.17M -4.27M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -94.42M -36.7M n/a 41.78M n/a -70.81M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-96.72M -644.14M -33.75M -292.34M -118.63M -309.98M n/a -12.16M -41.46M -81.33M -111.2M n/a -75M -82.52M -65.88M -145.51M -55.2M -40M n/a
Sales Maturities Of Investments
240.48M 229.23M 118.17M 93.7M 140.03M 75.12M 133.5M 106.57M 78.16M 72.58M 69.42M 69.16M 145.81M 17.51M 38.27M 35.46M 39.59M 13.12M 34.43M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a 94.42M 36.7M n/a -41.78M 69.16M 70.81M -65M -27.61M -110.05M -15.61M -26.88M 34.43M
Investing Cash Flow
141.39M -420.21M 76.91M -222.92M 6.95M -268.94M 64.84M 30.51M -9.9M -36.06M -80.69M 36.45M 61.28M -69.75M -33.38M -118.25M -19.54M -34.05M 30.16M
Debt Repayment
-47.9M -151.63M n/a 388.87M 50M n/a n/a 250M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5M n/a -5M n/a n/a n/a n/a -250.67M 1.14M 520K 250.58M 855K 60.6M 1.85M 1.89M 815K 2.75M 2.63M 5.1M
Financial Cash Flow
-42.68M 92.38M 20.63M 389.09M 50.39M 430.78M 267K 152K 1.14M 520K 250.58M 855K 60.6M 1.85M 1.89M 815K 2.75M 2.63M 5.1M
Net Cash Flow
-55.92M 131.82M -48.8M 33.29M -58.3M 69.49M -52.68M 5.56M -29.63M -67.29M 94.24M -31.43M 53.03M -5.18M -92.85M -141.55M -46.4M 232.46M -3.66M
Free Cash Flow
-157.08M 454.76M -153.79M -161.5M -129.87M -126.45M -186.5M -89.16M -68.05M -58.98M -114.43M -101.38M -78.38M 57.98M -67.13M -32.32M -33.54M 256.71M -43.19M